Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Author contributions WC: Conceptualization, Methodology, Validation, Writing original draft, Writing review & editing
When administered to patients with NASH for 12 weeks, aldafermin (up to 6 mg daily) reduced liver fat content by up to 60% relative to baseline, reduced ALT by about 50%, and decreased Pro-C3 by about 2025% (306)
Semaglutide data tells a similar story
doi: 10.1177/2040622315620180 35 CuomoA.BolognesiS.GoracciA.CiuoliC.Beccarini CrescenziB.MainaG.et al
US$ 22.61
US$ 21.28
US$ 20.54
US$ 28.69
